Redox International Group, Corp.: M&A transaction — Intorio Corp. reports change of control; founder sells 89% stake; new CEO appointed

Redox International Group, Corp.

Founder Gagi Gogolashvili sold 2,000,000 shares (89% of outstanding) to six accredited investors on May 16, 2024.
Gogolashvili resigned as CEO, President, and director; Han-Wen Ou appointed CEO, CFO, Secretary and sole Director.
Company address changed from Tbilisi, Georgia to 17875 Von Karman Avenue, Irvine, California 92614.
Dr. Han-Wen Ou holds degrees in functional medicine and clinical nutrition; previously resident at Taipei Veterans General Hospital.

item 5.01 item 5.02 item 8.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Han-Wen Ou

Chief Executive Officer, Chief Financial Officer, Secretary and sole Director

Redox International Group, Corp.

Effective: 2024-05-16
Filed: May 28, 2024, 7:59 PM ET

Dr. Han-Wen Ou was appointed as Chief Executive Officer, Chief Financial Officer, Secretary and sole Director.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Han-Wen Ou was appointed as Chief Executive Officer, Chief Financial Officer, Secretary and sole Director at Redox International Group, Corp..

Action: appointed
Role: Chief Executive Officer, Chief Financial Officer, Secretary and sole Director

Exact text from the filing

Dr. Han-Wen Ou was appointed as Chief Executive Officer, Chief Financial Officer, Secretary and sole Director.

View on SEC.gov

M&A Transactions SEC 8-K Item 2.01/5.01 confidence 0.9

Redox International Group, Corp. underwent a change of control (closed 2024-05-16).

Action: change of control
Closing: 2024-05-16

Exact text from the filing

Effective May 16, 2024, Gagi Gogolashvili, the previous sole officer and director and majority shareholder of Intorio, Corp. (the “Company”), entered into a stock purchase agreements for the sale of 2,000,000 shares of Common Stock of the Company, representing approximately 89% of the issued and outstanding shares of Common Stock of the Company as of such date

View on SEC.gov

24 m&a transactions filed in the last 30 days. Browse all m&a transactions →

Source: SEC EDGAR

accession 0001683168-24-003840

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.